Volume 24, Number 3—March 2018
Research
Major Threat to Malaria Control Programs by Plasmodium falciparum Lacking Histidine-Rich Protein 2, Eritrea
Table 1
Characteristic | Ghindae | Massawa | Overall |
---|---|---|---|
No. enrolled | 26 | 25 | 51 |
Mean age, y (range) | 29.15 (10–60) | 29.08 (7–68) | 29.12 (7–68) |
No. males:no. females (ratio) | 16:10 (1.6:1) | 13:12 (1.08:1) | 29: 22 (1.32:1) |
Travel history outside area of residence, no. positive/no. tested | 2/26 | 3/25 | 5/51 |
Clinical history in previous 2 weeks, no. positive/no. tested | |||
Any malaria symptoms | 25/26 | 24/25 | 49/51 |
Fever | 10/26 | 24/25 | 34/51 |
Antimalarial treatment | 0 | 0 | 0 |
Microscopy results | |||
No. P. falciparum positive | 26 | 25 | 50 |
GM parasite density, parasites/μL (95% CI), [range] | 6,851 (3,490–13,448) [16–71,000] | 5,304 (2,620–10,734) [55–100,000] | 6,059 (3,782–9,705) [16–100,000] |
PCR results | |||
No. P. falciparum positive | 26 | 24 | 50 |
No. P. vivax positive | 0 | 1 | 1 |
RDT results | |||
No. pan-pLDH positive | 26 | 25 | 51 |
No. HRP-based P. falciparum positive | 5 | 14 | 19 |
False-negative result for P. falciparum, % | 80.8 | 41.7 | 62.0 |
*GM, geometric mean; HRP2, histidine-rich protein 2; pLDH, Plasmodium lactate dehydrogenase; RDT, rapid diagnostic test.
Page created: February 15, 2018
Page updated: February 15, 2018
Page reviewed: February 15, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.